Výsledky vyhľadávania
- Évolution de la demande des examens de médecine nucléaire pour cancer de la prostate depuis l' enregistrement de la fluorocholine (18F): analyse sur deux ans á ľ hôpital Tenon / Balogova S., Kobetz A., Huchet V. et al. . Médecine Nucléaire . - Vol. 36 (2012), s. 363-370 [Dokument nie je vo fonde knižnice]
- Fluorocholine (18F) and sodium fluoride (18F) PET/CT in the detection of prostate cancer: prospective comparison of diagnostic performance determined by masked reading / Langsteger W., Balogova S., Huchet V. ... et al. . The quarterly journal of nuclear medicine and molecular imaging . - Vol. 55, no. 4 (2011), s. 448-457 [Dokument nie je vo fonde knižnice]
- Characterisation and initial staging of prostate cancer: prospective determination of FCH PET/CT impact and comparison of its diagnostic performance vs. Contrastenhanced CT or MRI / Balogova S. ... [et al.] . Nukleární medicína : molekulární výzkum, diagnostika a terapie. - ISSN 1805-1146 . - Roč. 1, č. 3 (2012), s. 3 . Sborník vybraných abstrakt
- C 3127
- Localisation of recurrent prostate cancer: prospective determination of FCH PET/CCT imapct and comparison of its diagnostic performance vs. contrast-enhanced CT or MRI / Huchet V ... [et al.] . Nuklearmedizin . - 6 (2011), s. A 153 [Dokument nie je vo fonde knižnice]
- Significance of high prostate fluorodeoxyglucose (18F) uptake in a patient with no history of prostate cancer. Clinical cases, review and meta-analysis of literature / Kaliska L. ... [et al.] . Médecine nucléaire. - ISSN 0928-1258 . - Vol. 38, no 4 (2014), s. 266-274 [Dokument nie je vo fonde knižnice]
- Tomographie par émission de positons et cancer de la prostate / Huchet V., Kerrou K., Balogova S. ... et al. . Médecine Nucléaire . - Vol. 32, no. 8 (2008), s. 409-417 [Dokument nie je vo fonde knižnice]